FDANews
FDAnews Device Daily Bulletin

FDA Grants Clearance for Joimax’s Vaporflex and Legato Electrosurgical Probes

Nov. 10, 2016

Joimax has received 510(k) clearance from the FDA to market its Vaporflex and Legato electrosurgical probes with radio-wave technology for open and endoscopic spine surgery.

The Joimax electrosurgical devices are comprised of a series of components to facilitate the delivery of electrical energy from an RF generator to the patient tissue for use in cutting and/or coagulation of tissue.

All Vaporflex and Legato probes use radio frequency which is generated by high oscillating electrical current received from a commercially available RF generator. — Cynthia Jessup

View today's stories